Evotec and TIAP Expand LAB150 BRIDGE Partnership to Include Amgen
yahoo.com
news
2022-10-17 11:15:00

AMGEN TO JOIN LAB150 TO BUILD CANADA'S NEXT GENERATION OF LIFE SCIENCE COMPANIES

HAMBURG, GERMANY and TORONTO, ON / ACCESSWIRE / October 17, 2022 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) and Toronto Innovation Acceleration Partners ("TIAP") today announced that the two companies have expanded LAB150, their translational BRIDGE partnership, to include Amgen as a strategic partner. The expansion goes along with a combined investment of US$ 14 m to expedite LAB150 programmes towards the formation of new companies.
